Recent Company News

• 10:12 PM ET Aug 20, 2025
  

  RBC Capital Markets transfers ALM.SM, BIOA.B.SS, FYB.GR, others

• 06:23 AM ET Aug 14, 2025
  

  StreetAccount Summary - European unusual volume traders

• 02:09 AM ET Aug 07, 2025
  

  Absci, Almirall to expand their ongoing AI Drug Discovery collaboration with Almirall's selection of second target aimed at dermatological indications ($2.91, 0.00)

• 07:17 AM ET Jul 25, 2025
  

  Autos/Parts, Healthcare and Personal/Household goods lead; Financial Services, Media and Real Estate lag:

• 04:17 AM ET Jul 25, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 04:11 AM ET Jul 25, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (68 total)

• 01:17 AM ET Jul 25, 2025
  

  Almirall reports H1 net income €28.4M ex-items vs FactSet €29.7M [3 est, €28-32M] (€10.76, 0.00)

• 11:00 PM ET Jul 20, 2025
  

  Sun Pharmaceutical Industries phase 3 clinical studies evaluating Tildrakizumab 100 mg (ILUMYA) in active psoriatic arthritis meets primary endpoint (INR 1693.25, 0.00)

• 01:37 AM ET Jul 18, 2025
  

  Almirall downgraded to hold from buy at Bestinver Securities (€10.68, 0.00)

• 01:53 AM ET Jul 16, 2025
  

  Almirall downgraded to neutral from buy at JB Capital Markets (€10.78, 0.00)